Form 4: Clover Health Investments Executive Karen Soares Reports Stock Transaction
SEC Form 4 Filing
Karen Soares, General Counsel & Secretary at Clover Health Investments, sold 7,444 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.
Summary
- Karen Soares, the General Counsel & Secretary of Clover Health Investments, reported a transaction involving the company's Class A Common Stock.
- On November 14, 2024, Ms. Soares disposed of 7,444 shares of Class A Common Stock.
- The shares were sold at a price of $3.08 per share.
- This transaction was to cover tax obligations arising from the vesting of restricted stock units (RSUs).
- The RSUs were originally granted on February 14, 2022, and vest quarterly.
- Following the transaction, Ms. Soares beneficially owns 1,396,760 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment. It is a neutral event.
Future Outlook
The remaining RSUs will continue to vest quarterly until February 14, 2026, subject to continued service of the Reporting Person.
Industry Context
This is a routine transaction related to executive compensation and is common for publicly traded companies. It does not indicate any specific trend or issue within the healthcare industry.
Comparison to Industry Standards
- Executive stock transactions are a common occurrence in publicly traded companies, particularly around vesting periods for equity compensation.
- The sale of shares to cover tax obligations is a standard practice and does not indicate any unusual activity compared to similar companies such as Humana, UnitedHealth Group, or Centene.
- The vesting schedule of the RSUs is also typical for executive compensation packages.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive to cover tax obligations.
- The transaction does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2022-02-14 | Date of original grant of time-based restricted stock units (RSUs) to Karen Soares. |
| 2024-11-14 | Date of the stock transaction where 7,444 shares were disposed of to cover tax obligations. |
| 2026-02-14 | Final vesting date for the remaining restricted stock units (RSUs). |
Keywords
Clover Health Investments, CLOV, Karen Soares, SEC Form 4, Stock Transaction, Restricted Stock Units, RSUs, Class A Common Stock, Insider Trading, Tax Obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.